STATE Trial: SusTained Attention Training to Enhance Sleep - Remote

STATE Trial: SusTained Attention Training to Enhance Sleep (Phase I- Remote Trial Arm)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03604380

Acronym

STATE

Enrollment

134

Registered

2018-07-27

Start date

2018-07-10

Completion date

2020-11-04

Last updated

2020-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia Chronic

Brief summary

This study is a validation study to document the acceptability of the Tonic and Phasic Alertness Training (TAPAT) program in older adults with chronic late-life insomnia. The goal of this study is to employ a computerized attention-training program, TAPAT, designed for chronic late-life insomnia in a remote, randomized, controlled trial to assess feasibility and initial efficacy in this population.

Interventions

OTHERComputerized Plasticity-Based Adaptive Cognitive Training

Computerized plasticity-based adaptive cognitive training requiring a total maximum of 36 treatment sessions, up to 7 sessions per week, 36 minutes per session.

OTHERActive Comparator

Commercially available computerized training requiring a total maximum of 36 treatment sessions, up to 7 sessions per week, 36 minutes per session.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

55 Years to No maximum

Healthy volunteers

Inclusion criteria

* Participant must be 55 years of age or older. * Participant must meet criteria for clinical insomnia - moderate severity based on the Insomnia Severity Index. * Participant must be a fluent English speaker. * Participant must have adequate visual, auditory, and motor capacity to use computerized intervention. * Participant must have a computer and access to the Internet.

Exclusion criteria

* Participants with untreated psychiatric conditions, including substance abuse/dependence disorders, untreated obstructive sleep apnea, diagnosis of other sleep disorders (e.g., restless legs syndrome), recent hospitalization, ongoing chemotherapy or other cancer treatment, and concurrent engagement in another insomnia treatment. * Participants enrolled in another concurrent research study. * Participants using computer-based cognitive training programs or has used them within a month of the consent date.

Design outcomes

Primary

Measure	Time frame
Sleep efficiency scores on the Pittsburg Sleep Quality Index	6 months
Sleep duration scores on the Pittsburg Sleep Quality Index	6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026